Loading stock data…
$3.46-0.04 (-1.14%)
Cryo-Cell International, Inc.
Cryo-Cell International, Inc. in the Healthcare sector is trading at $3.46 with a market capitalization of $29M. The stock is currently 36% below its 52-week high of $5.43, remaining 5.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.78M↑ | $7.68M↓ | $7.84M | — | $7.93M |
| Gross Profit | $6.10M↑ | $6.03M↓ | $6.11M | — | $6.07M |
| Operating Income | $1.20M↑ | $765,134↑ | $392,047 | — | $1.49M |
| Net Income | $554,586↑ | $47,108↑ | -$3.82M | — | $355,785 |
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical co...